These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 34256527)

  • 1. Gut dysbiosis, insulin resistance and Alzheimer's disease: review of a novel approach to neurodegeneration.
    Lazar E; Sherzai A; Adeghate J; Sherzai D
    Front Biosci (Schol Ed); 2021 Jun; 13(1):17-29. PubMed ID: 34256527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
    Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T
    Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.
    Bharadwaj P; Wijesekara N; Liyanapathirana M; Newsholme P; Ittner L; Fraser P; Verdile G
    J Alzheimers Dis; 2017; 59(2):421-432. PubMed ID: 28269785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term use of metformin and Alzheimer's disease: beneficial or detrimental effects.
    Al-Kuraishy HM; Al-Gareeb AI; Saad HM; Batiha GE
    Inflammopharmacology; 2023 Jun; 31(3):1107-1115. PubMed ID: 36849855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism involved in insulin resistance via accumulation of β-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer's disease.
    Rad SK; Arya A; Karimian H; Madhavan P; Rizwan F; Koshy S; Prabhu G
    Drug Des Devel Ther; 2018; 12():3999-4021. PubMed ID: 30538427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer's Disease and Type 2 Diabetes.
    Michailidis M; Moraitou D; Tata DA; Kalinderi K; Papamitsou T; Papaliagkas V
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.
    de la Monte SM
    Drugs; 2012 Jan; 72(1):49-66. PubMed ID: 22191795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease.
    Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M
    Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of insulin resistance in Alzheimer's disease.
    Cai Z; Xiao M; Chang L; Yan LJ
    Metab Brain Dis; 2015 Aug; 30(4):839-51. PubMed ID: 25399337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease.
    Zhao WQ; Townsend M
    Biochim Biophys Acta; 2009 May; 1792(5):482-96. PubMed ID: 19026743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus.
    Moroz N; Tong M; Longato L; Xu H; de la Monte SM
    J Alzheimers Dis; 2008 Sep; 15(1):29-44. PubMed ID: 18780965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease.
    Tong M; Neusner A; Longato L; Lawton M; Wands JR; de la Monte SM
    J Alzheimers Dis; 2009; 17(4):827-44. PubMed ID: 20387270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crucial players in Alzheimer's disease and diabetes mellitus: Friends or foes?
    Kubis-Kubiak AM; Rorbach-Dolata A; Piwowar A
    Mech Ageing Dev; 2019 Jul; 181():7-21. PubMed ID: 31085195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid-β and islet amyloid pathologies link Alzheimer's disease and type 2 diabetes in a transgenic model.
    Wijesekara N; Ahrens R; Sabale M; Wu L; Ha K; Verdile G; Fraser PE
    FASEB J; 2017 Dec; 31(12):5409-5418. PubMed ID: 28808140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment.
    Liu S; Gao J; Zhu M; Liu K; Zhang HL
    Mol Neurobiol; 2020 Dec; 57(12):5026-5043. PubMed ID: 32829453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer's Disease: Testosterone as a Modifier.
    Asih PR; Tegg ML; Sohrabi H; Carruthers M; Gandy SE; Saad F; Verdile G; Ittner LM; Martins RN
    J Alzheimers Dis; 2017; 59(2):445-466. PubMed ID: 28655134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?
    Stanley M; Macauley SL; Holtzman DM
    J Exp Med; 2016 Jul; 213(8):1375-85. PubMed ID: 27432942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease.
    Verdile G; Keane KN; Cruzat VF; Medic S; Sabale M; Rowles J; Wijesekara N; Martins RN; Fraser PE; Newsholme P
    Mediators Inflamm; 2015; 2015():105828. PubMed ID: 26693205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron metabolism in diabetes-induced Alzheimer's disease: a focus on insulin resistance in the brain.
    Chung JY; Kim HS; Song J
    Biometals; 2018 Oct; 31(5):705-714. PubMed ID: 30043289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.